IO Biotech (IOBT) Earnings Date & Reports

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IOBT is expected to report earnings to fall 29.07% to -30 cents per share on May 19

Q1'25

Est.

$-0.31

Q4'24

Missed

by $0.12

Q3'24

Missed

by $0.07

Q2'24

Beat

by $0.03

Q1'24

Beat

by $0.06

The last earnings report on March 27 showed earnings per share of -43 cents, missing the estimate of -31 cents. With 63.52K shares outstanding, the current market capitalization sits at 60.79M.

View a ticker or compare two or three

Compare

IOBT